155 related articles for article (PubMed ID: 1963909)
1. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
Dickstein K
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
[TBL] [Abstract][Full Text] [Related]
4. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
Hansen EF; Bendtsen F; Henriksen JH
Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
6. Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.
Nussberger J; Brunner DB; Waeber B; Biollaz J; Brunner HR
Clin Sci (Lond); 1987 Mar; 72(3):387-9. PubMed ID: 3028701
[TBL] [Abstract][Full Text] [Related]
7. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.
Kohzuki M; Johnston CI; Chai SY; Jackson B; Perich R; Paxton D; Mendelsohn FA
J Hypertens; 1991 Jul; 9(7):579-87. PubMed ID: 1653792
[TBL] [Abstract][Full Text] [Related]
8. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humans.
Vos PF; Boer P; Braam B; Koomans HA
Kidney Int; 1995 Jan; 47(1):274-81. PubMed ID: 7731158
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.
Ajayi AA; Campbell BC; Kelman AW; Howie C; Meredith PA; Reid JL
Int J Clin Pharmacol Res; 1985; 5(6):419-27. PubMed ID: 3005181
[TBL] [Abstract][Full Text] [Related]
12. A comparison of single doses of lisinopril and enalapril in hypertension.
Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
[TBL] [Abstract][Full Text] [Related]
13. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.
Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
Hypertension; 1988 Mar; 11(3):230-8. PubMed ID: 2832327
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Jackson B; Cubela R; Johnston CI
J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
[TBL] [Abstract][Full Text] [Related]
16. Abolition of long-term vascular influence of renin-angiotensin system.
Randall RD; Zimmerman BG
Am J Physiol; 1990 Aug; 259(2 Pt 2):H543-53. PubMed ID: 2167025
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
[TBL] [Abstract][Full Text] [Related]
18. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.
Hartmann JF; Szemplinski M; Hayes NS; Keegan ME; Slater EE
J Hypertens; 1988 Aug; 6(8):677-83. PubMed ID: 2846685
[TBL] [Abstract][Full Text] [Related]
19. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
Woie L; Dickstein K; Kaada B
Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
